PANTOPRAZOLE
Ampullary Cancer
Washington University School of MedicineSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Ampullary Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Docetaxel Minia University | Phase 3 | BB |
Dostarlimab UNICANCER | Phase 2 | CCC |
CIS-DIAMMINEDICHLOROPLATINUM II University of Nebraska | Phase 1 | CC |
Irinotecan University of Chicago | Phase 1 | CC |
ADH-1 TRIFLUROACETATE University of Nebraska | Phase 1 | CC |
FLUOROURACILUM Alliance for Clinical Trials in Oncology | Phase 1 | CC |
Eloxatin Alliance for Clinical Trials in Oncology | N/A | D |
Same molecule, other indications
PANTOPRAZOLE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →